RxDoctor Payments Data

Marianne Rios

Physician Assistant · San Antonio, TXNPI 1104409291

Payments from drug & device makers

$5,626in general payments, 2019–2025

Across 242 payments — averaging $23.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$1K
  • AbbVie$820
  • AstraZeneca$584
  • Pfizer$507
  • Astellas Pharma US Inc$348
  • Lilly USA, LLC$281
  • plus $2K from 27 others

What the payments were for

  • Food & beverage$5,47797%
  • Education$1493%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,626 in reported general payments places this provider in the 90th percentile of 8,308 physician assistant providers in Texas.

See all physician assistant providers in Texas

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol12$17,237
PaxlovidNirmatrelvir/Ritonavir14$2,858
Albuterol Sulfate HfaAlbuterol Sulfate18$443
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst17$332
Cefdinir17$299
Azelastine Hcl17$286
CefuroximeCefuroxime Axetil17$257
Levothyroxine Sodium19$200
Atorvastatin Calcium44$169
Escitalopram Oxalate19$167
Losartan Potassium25$163
Pantoprazole Sodium23$145
Clindamycin Hcl12$141
Mupirocin12$126
Rosuvastatin Calcium25$117

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga$584$17,23712 claims
PfizerPaxlovid$507$2,85814 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$47$20019 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 8,308 physician assistant providers in Texas.

Other physician assistant in San Antonio

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →